Bioatla Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.16

+0.01 (+4.55%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +5,738.5% upside

Low Target $5.45

Average Target $9.40

High Target $11.97

Current Price $0.16

Current
$0.16

Target
$9.40

$5.45 $9.40 avg $11.97

Scenario Analysis

Bear Case

$5.45

3,285.1%

Low target

Base Case

$9.40

+5,738.5%

Avg target

Bull Case

$11.97

+7,334.8%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$1.43

-88.7% from high

52-Week Low

$0.13

+23.8% from low

Target vs 52W High

$9.40

+557.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+18.4%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.8%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+160.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-1.8%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.1%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-28.5%